Heart Surgery

Latest Issue of OR Manager
May 2025
Home Surgery/Specialties > Heart Surgery

PCI vs CABG outcomes for left main coronary disease

Editor's Note In this study of patients with left main coronary disease, there was no significant difference in outcomes at 5 years between treatment with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Researchers randomly assigned 1,905 patients with left main coronary artery disease of low or intermediate…

Read More

By: Judy Mathias
October 7, 2019
Share

CMS considering reimbursement for coronary interventions at ASCs

Editor's Note In a proposed rule, the Centers for Medicare & Medicaid Services (CMS) is considering whether to reimburse for percutaneous coronary interventions (PCIs) at ambulatory surgical centers (ASCs), the September 20 tctMD reports. As of May 1, 2019, approximately 22 states allowed for coronary interventions to be done outside…

Read More

By: Judy Mathias
September 24, 2019
Share

Joint Commission posts new CCC Certification measure implementation guide

Editor's Note The Joint Commission on September 11 announced that it had posted a new version of the Comprehensive Cardiac Center (CCC) Certification program’s standardized measures implementation guide on its website with updated measure specifications. Beginning January 1, 2020, data collection on five new inpatient performance measures will be mandatory…

Read More

By: Judy Mathias
September 12, 2019
Share

9/11 World Trade Center exposure linked to long-term CVD risk in firefighters

Editor's Note In this study, a significant association was found between exposure to World Trade Center dust and long-term cardiovascular disease (CVD) risk in firefighters. Of 9,796 firefighters analyzed, those who arrived first at the World Trade Center when dust was the thickest were found to have a 44% increased…

Read More

By: Judy Mathias
September 9, 2019
Share

Sponsored Message

Joint Commission announces new Comprehensive Cardiac Center Certification performance measures

Editor's Note The Joint Commission on August 28 announced five new inpatient performance measures for the Comprehensive Cardiac Center Certification program, which will be effective January 1, 2020. Data collection for the measures will be mandatory for currently certified programs and organizations seeking initial certification. In addition to the mandatory…

Read More

By: Judy Mathias
August 29, 2019
Share

Machine learning algorithm predicts bleeding during CABG surgery

Editor's Note A machine learning algorithm based on data from the American College of Cardiology’s National Cardiovascular Data Registry accurately identified patients at risk for bleeding during or after coronary artery bypass grafting (CABG) surgery, the August 23 Health IT Analytics reports. Researchers developed the platform using a risk spectrum…

Read More

By: Judy Mathias
August 27, 2019
Share

Sponsored Message

ASC Manager Issue 2

Healthcare providers have seen a steady stream of inpatient-only procedures migrate to ambulatory surgery centers (ASCs) over the past few years. Medicare is reimbursing an increasing number of procedures performed in the outpatient setting, many of them cardiovascular in nature. This issue of ASC Manager explores the development of a…

Read More

By: Judy Mathias
August 23, 2019
Share

Cardiothoracic surgery patients at high risk for postop opioid dependence

Editor's Note This study finds that the amount of opioids prescribed for patients after cardiothoracic surgery has a direct relationship with the risk for opioid dependence and persistent opioid use several months after surgery. Of nearly 25,000 opioid-naïve Medicare patients analyzed, 15.7% of patients who had lung surgery and 12.5%…

Read More

By: Judy Mathias
August 22, 2019
Share

FDA: Class I recall of Edwards Lifesciences SAPIEN 3 Ultra Delivery System

Editor's Note The Food and Drug Administration on August 22 identified the recall by Edwards Lifesciences of all lots of its SAPIEN 3 Ultra Delivery System as Class I, the most serious. The delivery system is part of the Edwards SAPIEN 3 Transcatheter Heart Valve System. The recall was initiated…

Read More

By: Judy Mathias
August 22, 2019
Share

FDA: Class I recall of Ellipse Implantable Cardioverter Defibrillators

Editor's Note The Food & Drug Administration on August 5 identified the recall by Abbott (formerly St Jude Medical Inc) of its Ellipse Implantable Cardioverter Defibrillators as Class I, the most serious. The recall was initiated because electrical failures have been identified that are due to a faulty manufacturing process…

Read More

By: Judy Mathias
August 5, 2019
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat